Characterizing the Association Between Preoperative Depressive Symptoms and Opioid Use/Misuse After Surgery

December 12, 2024 updated by: Jennifer Hah, Stanford University

Observational Study to Characterize the Relationship Between Preoperative Depressive Symptoms and Opioid Use/Misuse After Surgery

This observational study aims to characterize the relationship between preoperative depressive symptoms and opioid use/ misuse after surgery using a perioperative learning health care system. We will follow a prospective cohort of patients undergoing elective surgery.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

718

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Palo Alto, California, United States, 94304
        • Stanford University School of Medicine
      • Stanford, California, United States, 94304
        • Stanford Health Care

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Patients undergoing elective surgery at Stanford Hospital.

Description

Inclusion Criteria:

  1. Age 18+
  2. Planning to undergo surgery
  3. English speaking
  4. Ability and willingness to complete questionnaires and assessments

Exclusion Criteria:

  1. Any conditions causing inability to complete assessments (education, cognitive ability, mental status, medical status)
  2. Known Pregnancy
  3. Elevated Suicidality
  4. Enrollment in a conflicting perioperative trial

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Patients undergoing elective operations
We will follow a prospective cohort of 558 patients, undergoing any elective surgery at Stanford Hospital. Subjects will undergo baseline and longitudinal testing via a (including NIH Patient-Reported Outcomes Measurement Information System- PROMIS measures of emotional distress). After surgery, participants will report weekly changes in opioid use, pain, and adverse events; and monthly changes in opioid misuse for 1 year.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Time to Opioid Cessation
Time Frame: Assessed after surgery up to 1 year
Assessed after surgery up to 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Opioid Misuse
Time Frame: Assessed after surgery up to 1 year
Participant score on the Current Opioid Misuse Measure will be used to assess opioid misuse
Assessed after surgery up to 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 10, 2019

Primary Completion (Actual)

March 3, 2024

Study Completion (Actual)

March 3, 2024

Study Registration Dates

First Submitted

June 6, 2022

First Submitted That Met QC Criteria

June 6, 2022

First Posted (Actual)

June 9, 2022

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 12, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 43163

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Opioid Use

Subscribe